XX-650-23 is a small molecule CREB inhibitor that blocks the critical interaction between CREB and its required coactivator, CBP (CREB-binding protein), inducing apoptosis and cell cycle arrest in AML cells, and can be used in the study of acute myelogenous leukaemia (AML).
Molecular Weight:
288.3
Purity:
97.01%
CAS Number:
[117739-40-9]
Formula:
C18H12N2O2
Target:
Apoptosis|||Epigenetic Reader Domain
T24212
* VAT and and shipping costs not included. Errors and price changes excepted